Insider · CIK 0002048497
Mark Hopman
Files at BBNX (Beta Bionics, Inc.). First filing Jun 4, 2025, latest Oct 5, 2026.
In brief
Mark Hopman files SEC Form 4 as officer at BBNX (Beta Bionics, Inc.). Since Jun 4, 2025, Mark Hopman has reported 0 open-market buys worth $0 and 16 open-market sells worth $2.9M, the latest filed on Oct 5, 2026.
A track record needs three past buys with six months of prices behind them; Mark Hopman has 0, so none is measured yet.
The newest scored trade: sold $7,015 of BBNX on Oct 1, 2026, filed Oct 5, 2026, scored 3 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 12 sells worth $2.3M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BBNX: Beta Bionics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 3Weak | Beta Bionics, Inc. | $7,015 370 shares | -1% | +113% from low-41% from high | |
| 40Moderate | Beta Bionics, Inc. | $665k 35,994 shares | -29% | +97% from low-46% from high | |
| 40Moderate | Beta Bionics, Inc. | $620k 30,779 shares | -35% | +150% from low-31% from high | |
| 10Weak | Beta Bionics, Inc. | $12k 775 shares | -1% | +89% from low-48% from high | |
| 41Moderate | Beta Bionics, Inc. | $681k 36,870 shares | -30% | +97% from low-46% from high | |
| 40Moderate | Beta Bionics, Inc. | $102k 5,327 shares | -4% | +119% from low-39% from high | |
| 10Weak | Beta Bionics, Inc. | $19k 1,258 shares | -1% | +66% from low-54% from high | |
| 10Weak | Beta Bionics, Inc. | $3,385 275 shares | -0% | +57% from low-57% from high | |
| 38Weak | Beta Bionics, Inc. | $67k 5,329 shares | -4% | +44% from low-60% from high | |
| 19Weak | Beta Bionics, Inc. | $88k 2,917 shares | -2% | +193% from low-10% from high | |
| 10Weak | Beta Bionics, Inc. | $4,084 353 shares | -0% | +17% from low-64% from high | |
| 30Weak | Beta Bionics, Inc. | $10k 834 shares | -1% | +29% from low-61% from high | |
| 20Weak | Beta Bionics, Inc. | $371k 18,229 shares | -48% | +107% from low-16% from high | |
| 30Weak | Beta Bionics, Inc. | $16k 848 shares | -2% | +96% from low-20% from high | |
| 18Weak | Beta Bionics, Inc. | $268k 16,158 shares | -32% | +64% from low-33% from high | |
| 30Weak | Beta Bionics, Inc. | $16k 868 shares | -2% | +92% from low-22% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 1, 2026 | BBNX BETA BIONICS, INC. | 2,660 0.01% of outstanding | $50k | Oct 1, 2026 | $1.4M |
| Sep 16, 2026 | BBNX BETA BIONICS INC | 28,119 0.06% of outstanding | $541k | Sep 16, 2026 | $813k |
| Sep 9, 2026 | BBNX BETA BIONICS, INC. | 40,305 0.09% of outstanding | $779k | Sep 9, 2026 | $121k |
| Sep 3, 2026 | BBNX BETA BIONICS, INC. | 5,327 0.01% of outstanding | $103k | Sep 2, 2026 | $89k |
| Jun 24, 2026 | BBNX Beta Bionics, Inc. | 1,258 0.00% of outstanding | $19k | Jun 24, 2026 | $72k |
| Jun 4, 2026 | BBNX Beta Bionics, Inc. | 275 0.00% of outstanding | $3,385 | Jun 4, 2026 | $72k |
| Jun 3, 2026 | BBNX BETA BIONICS, INC. | 5,329 0.01% of outstanding | $68k | Jun 2, 2026 | none |
| Mar 4, 2026 | BBNX Beta Bionics, Inc. | 353 0.00% of outstanding | $4,084 | Mar 4, 2026 | $63k |
| Dec 4, 2025 | BBNX Beta Bionics, Inc. | 2,061 0.00% of outstanding | $63k | Dec 4, 2025 | $371k |
| Sep 5, 2025 | BBNX Beta Bionics, Inc. | 11,411 0.03% of outstanding | $235k | Sep 5, 2025 | $420k |
| Sep 4, 2025 | BBNX Beta Bionics, Inc. | 6,818 0.02% of outstanding | $136k | Sep 4, 2025 | $284k |
| Aug 19, 2025 | BBNX Beta Bionics, Inc. | 16,158 0.04% of outstanding | $268k | Aug 19, 2025 | $16k |
Transactions
Every row this insider has filed, 39 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock10b5-1 | -370 | $18.96 | $7,015 | 56,109 | 8 d ago |
| Sep 9, 2026 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock10b5-1 | -35,994 | $18.46 | $665k | 88,033 | 25 d ago |
| Sep 16, 2026 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock10b5-1 | -30,779 | $20.13 | $620k | 56,479 | 26 d ago |
| Sep 14, 2026 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock10b5-1 | -775 | $15.52 | $12k | 86,382 | 28 d ago |
| Sep 9, 2026 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock10b5-1 | -36,870 | $18.46 | $681k | 87,157 | 33 d ago |
| Sep 2, 2026 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock | -5,327 | $19.11 | $102k | 124,027 | 40 d ago |
| Jun 24, 2026 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,258 | $15.01 | $19k | 129,354 | Jun 25, 2026 |
| Jun 4, 2026 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock10b5-1 | -275 | $12.31 | $3,385 | 130,612 | Jun 5, 2026 |
| Jun 2, 2026 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock | -5,329 | $12.61 | $67k | 130,887 | Jun 3, 2026 |
| Dec 2, 2025 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock10b5-1 | -856 | $29.34 | $25k | 138,277 | Mar 16, 2026 |
| Dec 4, 2025 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,061 | $30.66 | $63k | 136,216 | Mar 16, 2026 |
| Feb 27, 2026 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +91,520 | $0.00 | $0 | 91,520 | Mar 13, 2026 |
| Mar 4, 2026 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock10b5-1 | -353 | $11.57 | $4,084 | 139,133 | Mar 5, 2026 |
| Feb 27, 2026 | BBNX Beta Bionics, Inc. | AGrant or award Common Stock | +109,105 | $0.00 | $0 | 140,320 | Mar 3, 2026 |
| Mar 2, 2026 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock | -834 | $12.36 | $10k | 139,486 | Mar 3, 2026 |
| Feb 27, 2026 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +58,749 | $0.00 | $0 | 58,749 | Mar 3, 2026 |
| Sep 4, 2025 | BBNX Beta Bionics, Inc. | MOption exercise Common Stock10b5-1 | +656 | $5.10 | $3,346 | 33,940 | Sep 8, 2025 |
| Sep 4, 2025 | BBNX Beta Bionics, Inc. | MOption exercise Common Stock10b5-1 | +4,093 | $5.10 | $21k | 38,033 | Sep 8, 2025 |
| Sep 4, 2025 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,818 | $19.97 | $136k | 31,215 | Sep 8, 2025 |
| Sep 5, 2025 | BBNX Beta Bionics, Inc. | MOption exercise Common Stock10b5-1 | +11,411 | $5.10 | $58k | 42,626 | Sep 8, 2025 |
| Sep 5, 2025 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock10b5-1 | -11,411 | $20.56 | $235k | 31,215 | Sep 8, 2025 |
| Sep 4, 2025 | BBNX Beta Bionics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -656 | $0.00 | $0 | 66,428 | Sep 8, 2025 |
| Sep 4, 2025 | BBNX Beta Bionics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -4,093 | $0.00 | $0 | 33,136 | Sep 8, 2025 |
| Sep 5, 2025 | BBNX Beta Bionics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -11,411 | $0.00 | $0 | 21,725 | Sep 8, 2025 |
| Sep 2, 2025 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock | -848 | $18.86 | $16k | 33,284 | Sep 4, 2025 |
| Aug 19, 2025 | BBNX Beta Bionics, Inc. | MOption exercise Common Stock10b5-1 | +16,158 | $5.10 | $82k | 50,290 | Aug 20, 2025 |
| Aug 19, 2025 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock10b5-1 | -16,158 | $16.61 | $268k | 34,132 | Aug 20, 2025 |
| Aug 19, 2025 | BBNX Beta Bionics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -16,158 | $0.00 | $0 | 67,084 | Aug 20, 2025 |
| Jun 2, 2025 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock | -238 | $17.03 | $4,053 | 34,762 | Jun 4, 2025 |
| Jun 2, 2025 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock | -551 | $18.15 | $10k | 34,211 | Jun 4, 2025 |
| Jun 2, 2025 | BBNX Beta Bionics, Inc. | SOpen-market sale Common Stock | -79 | $18.69 | $1,477 | 34,132 | Jun 4, 2025 |
| Feb 27, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Common Stock | +35,000 | $0.00 | $0 | 35,000 | Mar 3, 2025 |
| Feb 27, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +52,000 | $0.00 | $0 | 52,000 | Mar 3, 2025 |
| Jan 31, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +83,242 | $0.00 | $0 | 83,242 | Feb 3, 2025 |
| Jan 31, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +37,229 | $0.00 | $0 | 37,229 | Feb 3, 2025 |
| Jan 31, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +17,765 | $0.00 | $0 | 17,765 | Feb 3, 2025 |
| Jan 31, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +39,424 | $0.00 | $0 | 39,424 | Feb 3, 2025 |
| Jan 31, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +47,775 | $0.00 | $0 | 47,775 | Feb 3, 2025 |
| Jan 29, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +47,775 | $0.00 | $0 | 47,775 | Jan 31, 2025 |
Questions about Mark Hopman
Answered from the filings on this page, as of the latest one.
Is Mark Hopman buying or selling?
In the last 12 months Mark Hopman reported 0 open-market buys worth $0 and 12 open-market sells worth $2.3M on SEC Form 4; the latest was sold $7,015 of BBNX on Oct 1, 2026. Grants, option exercises and tax withholding are not counted.
How did Mark Hopman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark Hopman has 0.
Where does Mark Hopman file Form 4?
Mark Hopman has filed Form 4 at BBNX (Beta Bionics, Inc.) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.